Stealth BioTherapeutics to Present at 28th Annual Piper Jaffray Healthcare Conference Press Release / November 28, 2016June 20, 2018
Stealth BioTherapeutics Announces Positive Phase 2 Clinical Trial Findings for Patients Undergoing Renal Angioplasty Press Release / November 18, 2016July 10, 2018
Stealth BioTherapeutics Initiates Phase 1 Study of Elamipretide in Dry Age-Related Macular Degeneration Press Release / November 14, 2016July 10, 2018
Stealth BioTherapeutics to Present at Stifel 2016 Healthcare Conference Press Release / November 9, 2016June 20, 2018
Stealth BioTherapeutics Announces Acceptance of Late-Breaking Clinical Trial Poster at American Society of Nephrology Kidney Week 2016 Press Release / November 7, 2016July 10, 2018
Stealth BioTherapeutics Initiates Phase 2 Study of Elamipretide in Patients Hospitalized with Congestive Heart Failure Press Release / October 25, 2016July 10, 2018
Stealth BioTherapeutics Reports Elamipretide Improved Skeletal Muscle Bioenergetics in the Elderly Press Release / September 19, 2016July 10, 2018
Stealth BioTherapeutics Initiates Phase 2 Study of Elamipretide in Primary Mitochondrial Disease Press Release / September 12, 2016July 10, 2018
Stealth BioTherapeutics to Participate in Upcoming Investor Conferences Press Release / September 6, 2016June 20, 2018
Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure Press Release / June 27, 2016July 10, 2018
